Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Twist reports preclinical data on antibodies against S1 protein in SARS-CoV-2

Nov. 25, 2020

FDA approves Xofluza for post-exposure prophylaxis of influenza

Nov. 25, 2020

Phase I/II study of SBI-101 for severe COVID-19 begins dosing

Nov. 24, 2020

First cohort data from phase I study of GRAd-COV2 show immune responses

Nov. 24, 2020

New antibodies for COVID-19 presented by University of Pittsburgh

Nov. 24, 2020

AiCuris synthesizes HBV capsid assembly inhibitors

Nov. 24, 2020

Chinese researchers patent compounds for liver diseases

Nov. 24, 2020

Sosei Heptares identifies antiviral small molecules for COVID-19

Nov. 24, 2020

Pooled analysis shows AZD-1222 effective at preventing COVID-19

Nov. 23, 2020

Phase II dosing begins with brequinar to treat COVID-19

Nov. 23, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...